Demystifying Clone-Censor-Weight Method in Target Trial Emulation: A Real-World Study of HPV Vaccination Strategies
Lin, T.; Li, Y.; Huang, Z.; Gui, T. T.; Wang, W.; Guo, Y.
Show abstract
Target trial emulation (TTE) offers a principled way to estimate treatment effects using real-world observational data, but analyses of time-varying treatment strategies remain vulnerable to immortal time bias. The clone-censor-weight (CCW) approach is increasingly used to address this problem, yet key aspects of its causal interpretation and implementation remain unclear. In this work, we emulate a target trial using electronic health records (EHRs) to compare completion of a 3-dose 9-valent human papillomavirus vaccination (HPV) series within 12 months versus remaining partially vaccinated among vaccine initiators. We link CCW to the classic potential outcome framework in causal inference, evaluate the role of different weighting mechanisms, and account for within-subject correlation induced by cloning using cluster-robust variance estimation. Our study provides practical guidance for applying CCW in real-world comparative effectiveness studies to address immortal time bias and supports more rigorous and interpretable treatment effect estimation in TTE.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- External control arm analysis: an evaluation of propensity score approaches, G-computation, and doubly debiased machine learning 95%
- Comparison of Bayesian networks, G-estimation and linear models to estimate causal treatment effects in aggregated N-of-1 trials 93%
- Prediction-powered Inference for Clinical Trials 92%
Similar papers in this journal
- Using numerical modelling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample 92%
- Evaluation of the United States COVID-19 Vaccine Allocation Strategy 92%
- Beyond the new normal: assessing the feasibility of vaccine-based elimination of SARS-CoV-2 92%
Similar papers in this journal
Similar papers in this journal
- Estimating Counterfactual Placebo HIV Incidence in HIV Prevention Trials Without Placebo Arms Based on Markers of HIV Exposure 94%
- Using simulated infectious disease outbreaks to guide the design of individually randomized vaccine trials 91%
- Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: a scoping review 91%
Similar papers in this journal
- Automated Interpretable Discovery of Heterogeneous Treatment Effectiveness: A Covid-19 Case Study 93%
- SurvMaximin: Robust Federated Approach to Transporting Survival Risk Prediction Models 92%
- Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.